-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMMIT THERAPUETICS FALL 25.8% PREMARKET AFTER FDA DECLINED APPROVAL OF CO'S LUNG CANCER DRUG

Reuters·11/16/2026 09:05:11

Please log in to view news